Pneumococcal vaccination coverage in at-risk children in Catalonia

被引:7
作者
Gonzalez, Roser [1 ]
Armadans, Lluis [1 ]
Martinez, Xavier [1 ]
Moraga, Fernando [2 ]
Campins, Magda [1 ]
机构
[1] Hosp Univ Vall dHebron, Serv Med Prevent & Epidemiol, Barcelona, Spain
[2] Hosp Univ Vall dHebron, Unidad Patol Infecciosa & Inmunodeficienc Pediat, Barcelona, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2015年 / 33卷 / 09期
关键词
Pneumococcal vaccination; Immunisation schedule; Vaccine coverage; Paediatric population; SPAIN; SEROTYPES;
D O I
10.1016/j.eimc.2015.01.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: The public health system in Catalonia only funds pneumococcal vaccination in paediatrics for children at-risk. The aim of this study was to determine pneumococcal vaccination coverage and its association with age, sociodemographic factors and other variables. Material and method: Descriptive cross-sectional study of children aged between 2 months and 15 years old assigned to primary care centres in Catalonia and with diseases that are included for pneumococcal vaccine in the official vaccination program. The information on vaccination status and study variables were obtained from data registered in the electronic medical records in the primary care centres. An analysis was made of the association between pneumococcal vaccination and demographic and medical variables using bivariate analysis and a multiple logistic regression model. The adjusted odds ratio (aOR), with a confidence interval of 95%, was used to measure the relationships. Results: Pneumococcal vaccination coverage was 47.7%. Variables which predicted pneumococcal vaccination were: age (aOR: 9.2 [7.9-10.7] in children 2 months-2 years old; aOR 8.1 [7.0-9.3] in children 3-5 years; aOR: 4.6 [4.0-5.2] in children 6-10 years), Spanish nationality (aOR: 3.9 [3.5-4.3]), correct immunisation according to systematic immunisation schedule (aOR: 2.5 [2.1-3.0]), and number of risk conditions (aOR: 3.2 [2.5-4.1] in children with 2 or more conditions). Conclusions: Pneumococcal vaccination coverage in children with risk conditions is low in Catalonia. Strategies need to be implemented to increase coverage. (C) 2015 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:597 / 602
页数:6
相关论文
共 20 条
  • [11] Generalitat de Catalunya Departament de Sanitat i Seguretat Social, 2001, PROT ADM VAC ANT CON
  • [12] Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
    Isaacman, Daniel J.
    McIntosh, E. David
    Reinert, Ralf R.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (03) : E197 - E209
  • [13] Istituto Superiore di Sanita. Gruppo di lavoro ICONA, 2008, ICONA 2008 IND COPER
  • [14] Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
    Johnson, Hope L.
    Deloria-Knoll, Maria
    Levine, Orin S.
    Stoszek, Sonia K.
    Hance, Laura Freimanis
    Reithinger, Richard
    Muenz, Larry R.
    O'Brien, Katherine L.
    [J]. PLOS MEDICINE, 2010, 7 (10)
  • [15] National Health System (NHS) Choices, NHS VACC SCHED
  • [16] Relationship between Serotypes, Age, and Clinical Presentation of Invasive Pneumococcal Disease in Madrid, Spain, after Introduction of the 7-Valent Pneumococcal Conjugate Vaccine into the Vaccination Calendar
    Picazo, J.
    Ruiz-Contreras, J.
    Casado-Flores, J.
    Giangaspro, E.
    Del Castillo, F.
    Hernandez-Sampelayo, T.
    Otheo, E.
    Balboa, F.
    Rios, E.
    Mendez, C.
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (01) : 89 - 94
  • [17] Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
    Pilishvili, Tamara
    Lexau, Catherine
    Farley, Monica M.
    Hadler, James
    Harrison, Lee H.
    Bennett, Nancy M.
    Reingold, Arthur
    Thomas, Ann
    Schaffner, William
    Craig, Allen S.
    Smith, Philip J.
    Beall, Bernard W.
    Whitney, Cynthia G.
    Moore, Matthew R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (01) : 32 - 41
  • [18] Republique Francaise, CAL VACC REC VACC 20
  • [19] Robert Koch Institut, 2014, VACC SCHED GERM STAN
  • [20] Córcoles AV, 2012, REV ESP SALUD PUBLIC, V86, P637, DOI 10.4321/S1135-57272012000600009